Bioconjugation Insights is an online, open access, peer-reviewed journal with an interdisciplinary, translational focus on all aspects and areas of the bioconjugation field, including ADCs, oligonucleotide conjugates, protein and peptide conjugates, PEGylation, radioconjugates, conjugated vaccines, diagnostics, and more.
Bioconjugation Insights is designed to provide the understanding and need-to-know information required to navigate this rapidly advancing sector. It serves as the go-to online resource for the latest news, trends, challenges, and breakthroughs in bioconjugation. You can find more information about our aims and scope here
Sign-up for free for unlimited access to all of our articles, webinars, podcasts, news, interviews, and more.
Nucleic Acid Insights covers the latest news, trends, issues, and breakthroughs across the rapidly evolving nucleic acids space, including oligonucleotides, mRNA, DNA, formulation and delivery, and more.
Our content - a balance of high-level analysis and in-depth technical data - is designed to give you the understanding and need-to-know information you require to successfully navigate this rapidly evolving space.
Sign up free for unlimited access to all of our articles, webinars, podcasts, infographics and more.
Vaccine Insights is a peer-reviewed, open-access journal covering the latest advances in the development and manufacturing of vaccines. See our Aims and scope for more detail on the topics covered.
Guided by an expert advisory board, the journal brings together leading experts from pharma, biotech, academia, and other key stakeholders to address critical issues and put the latest developments into context.
All content is free to view— sign up to explore reviews, commentary, interviews, webinars and more.
Closed Publications
Immuno-Oncology Insights has ceased publication. However, all published content remains available here. |
Immuno-Oncology Insights was an open access, independently peer reviewed publication specifically designed to fill a number of clear and important gaps in the slate of journals for the industrial and academic and immuno-oncology communities.
Guided by an editorial board lead by Jon Wigginton and Renier J Brentjens, Immuno-Oncology Insights placed R&D and manufacturing challenges and progress across a wide variety of technology fields in context.
To find out more or to access some of our fantastic content, visit Immuno-Oncology Insights.